VK2735

VK2735 is a dual agonist of the GIP receptor and GLP-1 receptor, 

  with a similar mechanism of action to that of tirzepatide ‒ a drug for diabetes. It can be injected via human skin. It is made by the pharmaceutical company Viking Therapeutics.

References

Category:Chemicals